secwatch.observer — SEC 8-K summary
======================================

Issuer:     Chemours Co (CC)
CIK:        0001627223
Form:       8-K
Filed at:   2024-03-26T23:59:59+00:00
Accession:  0001193125-24-077725
Event type: other_material
Sentiment:  neutral
Materiality: 0.10
Item codes: 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Chemours schedules Q4/FY23 earnings release for March 27, conference call March 28
--------------------------------------------------------------------------------

- Expects to issue Q4 and full-year 2023 financial results after market close on March 27, 2024.
- Annual Report on Form 10-K for year ended December 31, 2023 also to be filed March 27.
- Conference call to discuss results at 8:00 a.m. EDT on March 28, 2024; webcast on investors.chemours.com.
- Interim CFO Matthew Abbott signed the filing; no financial results disclosed in this 8-K.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1627223/000119312524077725/0001193125-24-077725-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1627223/000119312524077725/d782971d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-24-077725

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer